Loading...

Linical Co., Ltd.

2183.TJPX
Healthcare
Biotechnology
¥336.00
¥5.00(1.51%)

Linical Co., Ltd. (2183.T) Company Profile & Overview

Explore Linical Co., Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Linical Co., Ltd. (2183.T) Company Profile & Overview

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

SectorHealthcare
IndustryBiotechnology
CEOKazuhiro Hatano

Contact Information

81 6 6150 2478
Shin-Osaka Brick Building, Osaka, 532-0003

Company Facts

662 Employees
IPO DateOct 27, 2008
CountryJP
Actively Trading

Frequently Asked Questions

;